
Qingdao
603739.SSQingdao Vland Biotech INC. Price (603739.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
252,209,098
(2.4993)%Revenue and Profitability
Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 728,223,334 | 751,723,670 | 781,229,944 | 799,439,774 | 813,970,528 | 846,777,962 | 960,249,354 | 1,150,823,565 | 1,163,162,781 | 1,198,902,103 |
Net Income | 53,234,920 | 70,265,775 | 82,550,442 | 85,625,176 | 83,384,938 | 77,752,946 | 108,976,210 | 132,573,196 | 69,842,007 | 80,706,911 |
FCF USD | 7,618,114 | 18,952,943 | 127,937,539 | 63,853,290 | 14,187,331 | -54,841,850 | -38,831,706 | -404,064,093 | -246,716,728 | -62,050,419 |
OCF USD | 58,547,600 | 74,268,465 | 154,487,354 | 121,900,844 | 85,751,379 | 65,327,125 | 172,997,190 | 89,513,699 | 95,306,379 | 153,592,316 |
Financial Health - DEBT
Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
YTPD | 0.00 | 0.19 | 0.00 | 0.03 | 0.02 | 0.07 | 0.00 | 0.66 | 1.74 | 0.60 |
D/E | 0.30 | 0.20 | 0.06 | 0.14 | 0.18 | 0.04 | 0.07 | 0.15 | 0.32 | 0.37 |
CA/CL | 1.73 | 1.76 | 2.02 | 1.94 | 1.82 | 3.84 | 2.72 | 2.61 | 1.50 | 1.03 |
TA/TL | 2.42 | 2.72 | 3.07 | 3.04 | 3.01 | 5.15 | 4.32 | 4.14 | 3.05 | 2.51 |
Total Debt | 130,000,000 | 95,000,000 | 30,000,000 | 75,000,000 | 105,000,000 | 36,900,000 | 67,829,690 | 235,928,248 | 523,215,958 | 631,031,708 |
Management Performance
Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
ROIC | 5.25% | 8.16% | 11.59% | 12.41% | 11.36% | 7.90% | 9.95% | 7.54% | 3.73% | 4.10% |
ROE | 12.26% | 14.52% | 15.98% | 15.73% | 14.64% | 8.08% | 10.54% | 8.26% | 4.25% | 4.72% |
ROA | 0.00% | 9.45% | 10.81% | 10.47% | 9.83% | 6.98% | 8.43% | 6.76% | 3.31% | 3.39% |
NM % | 7.31% | 9.35% | 10.57% | 10.71% | 10.24% | 9.18% | 11.35% | 11.52% | 6.00% | 6.73% |
FCF / R% | 0.00% | 2.52% | 16.38% | 7.99% | 1.74% | -6.48% | -4.04% | -35.11% | -21.21% | -5.18% |
FCF / NI% | 12.77% | 24.40% | 142.96% | 69.01% | 15.27% | -61.35% | -31.75% | -269.20% | -288.86% | -60.33% |
Operating Margin (OM) | 0.00 | 0.47 | 0.48 | 0.50 | 0.51 | 0.55 | 0.55 | 0.54 | 0.56 | 0.59 |
Per Share
Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
EPS | 0.33 | 0.44 | 0.51 | 0.53 | 0.51 | 0.36 | 0.50 | 0.54 | 0.28 | 0.32 |
SPS | 4.50 | 4.66 | 4.80 | 4.94 | 5.02 | 3.91 | 4.43 | 4.69 | 4.61 | 4.75 |
OCPS | 0.36 | 0.46 | 0.95 | 0.75 | 0.53 | 0.30 | 0.80 | 0.36 | 0.38 | 0.61 |
FCPS | 0.05 | 0.12 | 0.79 | 0.39 | 0.09 | -0.25 | -0.18 | -1.65 | -0.98 | -0.25 |
BVPS | 2.88 | 3.22 | 3.43 | 3.66 | 3.89 | 4.77 | 5.15 | 6.87 | 6.87 | 7.24 |
Per Share - CAGR
Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
CAGR-EPS | 0.33 | 0.44 | 0.51 | 0.53 | 0.51 | 0.36 | 0.50 | 0.54 | 0.28 | 0.32 |
CAGR-SPS | 4.50 | 4.66 | 4.80 | 4.94 | 5.02 | 3.91 | 4.43 | 4.69 | 4.61 | 4.75 |
CAGR-OCPS | 0.36 | 0.46 | 0.95 | 0.75 | 0.53 | 0.30 | 0.80 | 0.36 | 0.38 | 0.61 |
CAGR-FCPS | 0.05 | 0.12 | 0.79 | 0.39 | 0.09 | -0.25 | -0.18 | -1.65 | -0.98 | -0.25 |
CAGR-BVPS | 2.88 | 3.22 | 3.43 | 3.66 | 3.89 | 4.77 | 5.15 | 6.87 | 6.87 | 7.24 |